Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
355
-
Total 13F shares, excl. options
-
86,958,278
-
Shares change
-
+3,326,885
-
Total reported value, excl. options
-
$5,499,043,282
-
Value change
-
+$226,844,283
-
Put/Call ratio
-
90.5%
-
Number of buys
-
199
-
Number of sells
-
-141
-
Price
-
$63.23
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2016
411 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2016.
RESMED INC - Common Stock (RMD) has 355 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86,958,278 shares
of 146,467,184 outstanding shares and own 59.4% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11,679,325 shares), Capital World Investors (7,916,234 shares), FMR LLC (5,909,395 shares), BlackRock Fund Advisors (5,908,048 shares), STATE STREET CORP (4,472,343 shares), BlackRock Institutional Trust Company, N.A. (4,364,339 shares), Bank of New York Mellon Corp (2,451,965 shares), COMMONWEALTH BANK OF AUSTRALIA (2,026,925 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1,805,944 shares), and PRUDENTIAL PLC (1,386,334 shares).
This table shows the top 355 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.